COMMUNIQUÉS West-GlobeNewswire

New 23andMe Research Institute Study First to Identify Association Between Specific Side Effects from Common Antidepressants and Genetics
05/08/2026
Study with more than 100,000 consented participants shows CYP2C19 genetic variation is associated with an individual’s risk of side effects and their continued use of serotonin reuptake inhibitors (SSRIs) PALO ALTO, [...]
Canadian Red Cross launches appeal to support communities impacted by wildfires in British Columbia
05/08/2026
Funds raised will help people affected by the wildfires with their recovery OTTAWA, Ontario, Aug. 05, 2026 (GLOBE NEWSWIRE) -- The Canadian Red Cross has launched the 2026 British Columbia Wildfires Appeal to support [...]
La Croix-Rouge canadienne lance un fonds de secours pour les communautés touchées par les feux de forêt en Colombie-Britannique
05/08/2026
Les sommes amassées soutiendront le rétablissement des personnes touchées par les incendies OTTAWA, Ontario, 05 août 2026 (GLOBE NEWSWIRE) -- La Croix-Rouge canadienne lance le Fonds de secours : Feux de forêt de 2026 [...]
THCA Gummies: Passion Farms Expands Its Product Portfolio with Premium THCA Edibles
05/08/2026
Passion Farms expands its premium THCA edibles portfolio, reinforcing its commitment to quality, consistency, and transparency while meeting the growing demand for premium edible products HOUSTON, Aug. 05, 2026 (GLOBE [...]
Novo Nordisk wins Dutch court injunction protecting patients from unapproved, unlawful compounded semaglutide nasal spray
05/08/2026
Novo Nordisk won a preliminary injunction against Ceban Ziekenhuisfarmacie B.V. from the District Court of The Hague in a patent infringement case involving a compounded semaglutide nasal spray The Court found that [...]
Stryker declares an $0.88 per share quarterly dividend
05/08/2026
Portage, Michigan, Aug. 05, 2026 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced that its Board of Directors has declared a quarterly dividend of $0.88 per share payable October 30, 2026, to shareholders of record at [...]
Acentra Health Acquires FEI Systems to Expand Technology and Clinical Solutions for Medicaid, Long-Term Services and Supports, Home- and Community-Based Services, and Behavioral Health
05/08/2026
Combined company creates a premier partner for government healthcare programs with end-to-end clinical services and modern health technology solutions MCLEAN, Va., Aug. 05, 2026 (GLOBE NEWSWIRE) -- Acentra Health, a [...]
CORRECTION: Ascentage Pharma to Report 2026 Six Month Interim Results and Provide Corporate Update on August 19, 2026
05/08/2026
In a release issued under the same headline earlier today by Ascentage Pharma Group International (NASDAQ: AAPG; HKEX: 6855), please note that in the first paragraph of the release, the time should be 7:00 am Eastern [...]
PacBio Announces Faster Runs, Up to 50% More HiFi Data, and New Compliance Controls for the Vega system
05/08/2026
Vega SPRQ-Nx chemistry to deliver up to 90 Gb per run at 40% lower cost per gigabase, with single-shift runs and new workflow controls for regulated labs MENLO PARK, Calif., Aug. 05, 2026 (GLOBE NEWSWIRE) -- PacBio ( [...]
China SXT Pharmaceuticals, Inc. Announces Share Consolidation
05/08/2026
TAIZHOU, China, Aug. 05, 2026 (GLOBE NEWSWIRE) -- China SXT Pharmaceuticals, Inc. (NASDAQ: SXTC) (the “Company”), today announced that it will effect a share consolidation of its Class A ordinary shares, no par value [...]
Athelas Launches Practice Manager, the World's First Agentic Practice Management Suite
05/08/2026
One platform. 7% of US healthcare appointments. Billions in claims. Practice Manager debuts alongside the new athelas.com website. SAN FRANCISCO, Aug. 05, 2026 (GLOBE NEWSWIRE) -- Athelas , powered by Commure, today [...]
Teknova Launches Build-Tek™, a Proprietary AI Reagent Assistant That Allows Customers to Configure Complex Custom Product Requests in Minutes
05/08/2026
Therapeutic and diagnostic developers gain flexibility, speed, and scalability to advance custom formulations from preclinical research to manufacturing for clinical trials, with a reviewed quote returned in under three [...]
STERIS To Invest $600 Million to Build a Formulated Chemistries Manufacturing and Distribution Center of Excellence in North Carolina
05/08/2026
• This Formulated Chemistries Center of Excellence will support sterilization and disinfection for the global Healthcare and Pharmaceutical industries • This strategic manufacturing investment is the largest in STERIS’s [...]
IAOMT Supports HHS Directive to Phase Out Mercury Dental Fillings in Medicaid
05/08/2026
CHAMPIONS GATE, Fla., Aug. 05, 2026 (GLOBE NEWSWIRE) -- The International Academy of Oral Medicine and Toxicology (IAOMT) strongly endorses a historic directive from the U.S. Department of Health and Human Services (HHS [...]
BiomX Acquires 10% Stake in Motomea, Inventor of Advanced Electric Motor Technologies for Drone and Autonomous Systems
05/08/2026
Agreement includes an exclusive drone distribution license and an option to acquire a controlling interest in Motomea NETANYA, Israel, Aug. 05, 2026 (GLOBE NEWSWIRE) -- BiomX Inc. (NYSE American: PHGE) (“BiomX” or the “ [...]
Adneuris Therapeutics Grants Exclusive License to Maruishi Pharmaceutical to Advance Cebranopadol in Japan and South Korea
05/08/2026
Agreement Grants Maruishi Rights for the Development and Commercialization of Cebranopadol for Pain in Japan and South Korea, Marking Adneuris' Second Ex-U.S. Licensing Transaction Under the Terms of the Agreement, [...]
Journey Medical Corporation to Announce Second Quarter 2026 Financial Results on August 12, 2026
05/08/2026
Company to host conference call to discuss financial results and provide a corporate update on August 12, 2026 at 4:30 p.m. ET SCOTTSDALE, Ariz., Aug. 05, 2026 (GLOBE NEWSWIRE) -- Journey Medical Corporation (“Journey [...]
Intelligent Bio Solutions Completes Usability Study Supporting FDA 510(k) Submission
05/08/2026
Study confirms the system can be effectively administered by operators with no specialist background NEW YORK, Aug. 05, 2026 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) ("INBS" or the "Company"), a [...]
Propanc Biopharma Completes First Tranche of $5.0 Million Share Repurchase Program
05/08/2026
Purchasing $500,000 within First 30 days Since Program Commencement MELBOURNE, Australia, Aug. 05, 2026 (GLOBE NEWSWIRE) -- Propanc Biopharma, Inc. (Nasdaq: PPCB) (“Propanc” or the “Company”), a biopharmaceutical [...]

Pages